CoChat

Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease

Open access
Ngo, Vy, Duennwald, Martin L. · 2022 · Antioxidants

The DOI matches its Crossref record; 235 of the 236 references it cites were found in a registry or an index; 50 of the 187 sources its claims cite were checked for support.

Abstract

Organisms are continually exposed to exogenous and endogenous sources of reactive oxygen species (ROS) and other oxidants that have both beneficial and deleterious effects on the cell. ROS have important roles in a wide range of physiological processes; however, high ROS levels are associated with oxidative stress and disease progression. Oxidative stress has been implicated in nearly all major human diseases, from neurogenerative diseases and neuropsychiatric disorders to cardiovascular disease, diabetes, and cancer. Antioxidant defence systems have evolved as a means of protection against oxidative stress, with the transcription factor Nrf2 as the key regulator. Nrf2 is responsible for regulating an extensive panel of antioxidant enzymes involved in the detoxification and elimination of oxidative stress and has been extensively studied in the disease contexts. This review aims to provide the reader with a general overview of oxidative stress and Nrf2, including basic mechanisms of Nrf2 activation and regulation, and implications in various major human diseases.

Overview

CoChat Summary

TL;DR

This narrative review summarizes oxidative stress and the Keap1-Nrf2 antioxidant pathway, covering Nrf2 activation, regulation, and interacting proteins. It highlights Nrf2 as the master regulator of antioxidant and phase II enzymes, with protective roles in many diseases but also a harmful “dark side” in cancer.

Key findings

  • Nrf2 is the key transcriptional regulator of ARE-driven antioxidant and phase II enzyme genes; under basal conditions Nrf2 has a short half-life of only 10–30 min, and Keap1 mediates its Cul3-dependent ubiquitination and proteasomal degradation.
  • Keap1 senses oxidative stress through reactive cysteines: human Keap1 contains 27 cysteine residues, about 4% of its amino acid content versus a 2% average for the human proteome; Cys273 and Cys288 are required for sensing oxidative stress under basal and stress conditions, while Cys151 may be required only during oxidative stress.
  • The Keap1-Nrf2 two-site recognition model depends on the high-affinity ETGE motif and low-affinity DLG motif; the ETGE motif has a binding affinity two orders of magnitude higher than the DLG motif, making DLG an “on/off switch” for Nrf2 ubiquitination.
  • Nrf2 is implicated in major human diseases: reduced nuclear Nrf2 is observed in Alzheimer’s disease brain regions; Nrf2 pathway alterations occur in 34% of squamous cell lung cancer specimens; and Nrf2 hyperactivation can promote chemoresistance to drugs such as cisplatin, 5-fluorouracil, docetaxel, and bortezomib.

Methods

  • Design: narrative review providing a general overview of oxidative stress, Nrf2 mechanisms, and implications in human disease.
  • Data or sample: no primary experimental data or human/animal sample; the paper synthesizes published literature and cites prior studies, reviews, and model-organism findings.
  • Main analysis: descriptive synthesis of ROS/RNS biology, antioxidant enzymes, ARE regulation, canonical and non-canonical Keap1-Nrf2 regulation, Nrf2-interacting proteins, and disease associations including neurodegenerative disease, neuropsychiatric disorders, cardiovascular disease, diabetes, cancer, inflammation, and aging.

Limitations

  • The paper does not state formal limitations; it describes the review as a “general overview” and notes that several topics are “briefly discussed” or “beyond the scope of this review.”
  • Evident from the text: as a narrative review, it lacks a systematic search strategy, predefined inclusion criteria, or quantitative synthesis, and it presents no primary data.
  • Evident from the text: disease sections are broad and selective rather than exhaustive, and the authors repeatedly refer readers to other reviews for more detailed discussion.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/antiox11122345

Cites

235 of 235 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Sources of exogenous and endogenous ROS. ROS can come from toxic exogenous sources in the environment, or be produced as by-products of normal cell metabolism, inflammation, and immunity. ROS may also function as secondary messengers within cell signalling pathways.
Figure 1 Sources of exogenous and endogenous ROS. ROS can come from toxic exogenous sources in the environment, or be produced as by-products of normal cell metabolism, inflammation, and immunity. ROS may also function as secondary messengers within cell signalling pathways.CC BY · PubMed Central
Figure 2 Transcriptional regulation of antioxidant genes by the ARE and Nrf2. Nrf2 heterodimerizes with sMaf proteins and binds to the ARE found within the promoter regions of antioxidant and phase II enzyme genes to activate their transcription.
Figure 2 Transcriptional regulation of antioxidant genes by the ARE and Nrf2. Nrf2 heterodimerizes with sMaf proteins and binds to the ARE found within the promoter regions of antioxidant and phase II enzyme genes to activate their transcription.CC BY · PubMed Central
Figure 3 The Keap1-Nrf2 pathway. Under basal conditions, Keap1 is bound to Nrf2, and Nrf2 is ubiquitinated by the Cul3 E3 ubiquitin ligase for degradation by the proteasome. Upon oxidative stress, sensor cysteines in Keap1 are modified by ROS, leading to Nrf2 stabilization, accumulation, and translocation to the nucleus where Nrf2 heterodimerizes with sMaf and binds to the ARE to activate the transcription of antioxidant genes.
Figure 3 The Keap1-Nrf2 pathway. Under basal conditions, Keap1 is bound to Nrf2, and Nrf2 is ubiquitinated by the Cul3 E3 ubiquitin ligase for degradation by the proteasome. Upon oxidative stress, sensor cysteines in Keap1 are modified by ROS, leading to Nrf2 stabilization, accumulation, and translocation to the nucleus where Nrf2 heterodimerizes with sMaf and binds to the ARE to activate the transcription of antioxidant genes.CC BY · PubMed Central
Figure 4 Domain structure of human Nrf2. Nrf2 contains seven conserved Neh domains. The Neh2 domain contains two motifs (29DLG31 and 79ETGE82) wherein Keap1 binds as a substrate adaptor for the Cul3-mediated ubiquitination and degradation of Nrf2.
Figure 4 Domain structure of human Nrf2. Nrf2 contains seven conserved Neh domains. The Neh2 domain contains two motifs (29DLG31 and 79ETGE82) wherein Keap1 binds as a substrate adaptor for the Cul3-mediated ubiquitination and degradation of Nrf2.CC BY · PubMed Central
Figure 5 Domain structure of human Keap1. Keap1 contains three functional domains and a 3-box motif within the proximal part of the IVR domain. The location of all cysteine (C) residues in Keap1 is shown, and key stress-sensing cysteines are marked with an asterisk (*).
Figure 5 Domain structure of human Keap1. Keap1 contains three functional domains and a 3-box motif within the proximal part of the IVR domain. The location of all cysteine (C) residues in Keap1 is shown, and key stress-sensing cysteines are marked with an asterisk (*).CC BY · PubMed Central
Figure 6 Stress-induced cysteine modification of Keap1. Under oxidative stress conditions, specific stress-sensing cysteine residues in Keap1 are modified, leading to a conformational change in Keap1 that results in Nrf2 stabilization, accumulation, and nuclear translocation for the induction of ARE-containing cytoprotective genes.
Figure 6 Stress-induced cysteine modification of Keap1. Under oxidative stress conditions, specific stress-sensing cysteine residues in Keap1 are modified, leading to a conformational change in Keap1 that results in Nrf2 stabilization, accumulation, and nuclear translocation for the induction of ARE-containing cytoprotective genes.CC BY · PubMed Central
Figure 7 Two-site substrate recognition model for Keap1-dependent Nrf2 regulation. (A) A Keap1 homodimer binds to the Neh2 domain of Nrf2 at the DLG and ETGE motifs, allowing for the ubiquitination of Nrf2 by Cul3. (B) Stress-sensing cysteine residue(s) in Keap1 are modified by oxidative stress (ROS) causing a conformational change in Keap1 that impairs Nrf2-binding. Nrf2 is stabilized and no ubiquitination occurs.
Figure 7 Two-site substrate recognition model for Keap1-dependent Nrf2 regulation. (A) A Keap1 homodimer binds to the Neh2 domain of Nrf2 at the DLG and ETGE motifs, allowing for the ubiquitination of Nrf2 by Cul3. (B) Stress-sensing cysteine residue(s) in Keap1 are modified by oxidative stress (ROS) causing a conformational change in Keap1 that impairs Nrf2-binding. Nrf2 is stabilized and no ubiquitination occurs.CC BY · PubMed Central
Figure 8 The aberrant Keap1-Nrf2 pathway in cancer. Some mutations are associated with Nrf2 hyperactivation, which protects cancer cells from ROS and chemotherapeutic agents by increased antioxidant activity.
Figure 8 The aberrant Keap1-Nrf2 pathway in cancer. Some mutations are associated with Nrf2 hyperactivation, which protects cancer cells from ROS and chemotherapeutic agents by increased antioxidant activity.CC BY · PubMed Central
Figure 9 Nrf2 protects cancer cells from cancer therapy. Cancer cells hijack the Nrf2 pathway to confer protection against cancer therapies such as chemotherapy and radiation. Cancer cells that survive therapy develop resistance and proliferate, leading to chemoresistance and cancer progression.
Figure 9 Nrf2 protects cancer cells from cancer therapy. Cancer cells hijack the Nrf2 pathway to confer protection against cancer therapies such as chemotherapy and radiation. Cancer cells that survive therapy develop resistance and proliferate, leading to chemoresistance and cancer progression.CC BY · PubMed Central

Verification

Claims the paper makes

23 Valid · 5 Not valid · 72 Not checked · 17 Own results and interpretations

67 more claims · 13 with their cited sources checked

Create a free account to see all 117 claims and to verify the 137 references still open.

See all claims — free account
  • It may state two separate claims as one. 42
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

1 retracted

Items 201–235 of 235

Cited by

See all 1,130

Metadata

Authors
Ngo, V., & Duennwald, M. L.
Affiliations
Western University (CA)
Corresponding author
Duennwald, Martin L.
Venue
Antioxidants
Publisher
MDPI AG
Published
2022-11-27
Volume
11
Issue
12
Pages
2345
ISSN
2076-3921 (ISSN-L)
OpenAlex
W4310211651
Cited by
1,130
References
236
Citations by year
2026: 415 · 2025: 448 · 2024: 200 · 2023: 67
FWCI
18.61
Type
journal article
Language
en
Open access
Locations
  • Antioxidants (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
TBCRU (n/a)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
Keywords
Nrf2, oxidative stress, reactive oxygen species, antioxidant defense, antioxidant enzymes, Nrf2 activation, neurodegenerative diseases, cardiovascular disease, diabetes mellitus, cancer, detoxification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.